Form 4 AMERICAN VANGUARD CORP For: May 15 Filed by: Macicek Steven D
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color: green;
background-color: white;
... (continue reading...)
Form D/A Red Hills Rail I, L.P.
.FormData {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
}
.FormDataR {
color: blue;
background-color: white;
font-size: 12px;
font-family: Times, serif;
text-align: right;
}
.SmallFormData {
color: blue;
background-color: white;
font-size: 10px;
font-family: Times, serif;
}
.FootnoteData {
color:... (continue reading...)
Form 6-K/A MOLECULAR PARTNERS AG For: Mar 31
UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 6-K/A REPORT OF FOREIGN PRIVATE ISSUERPURSUANT TO RULE 13a-16 OR 15d-16UNDER THE SECURITIES EXCHANGE ACT OF 1934For the Month of May 2024Commission File Number: 001-40488 MOLECULAR PARTNERS AG(Translation of registrant's name into English) Wagistrasse 148952 Zürich-SchlierenSwitzerlandTelephone: +41 447557700 (Address of registrant’s principal executive offices) Indicate by check mark whether... (continue reading...)
Form F-1 Telix Pharmaceuticals
http://archive.fast-edgar.com/20240517/AV2FH22CZM22FJKU222D2Z42TTSBZC22Z262
Filed on: May 17, 2024
Form 6-K Noah Holdings Ltd For: May 17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2024
Commission file number: 001-34936
Noah Holdings Limited
No.1226, South Shenbin Road, Minhang District,
Shanghai, People’s Republic of China
+86 (21) 8035-8292
More SEC Filings
View Older Stories-
Form 6-K Banco Santander, S.A. For: May 17
-
Form D/A Stillpoint Offshore Inve
-
Form 144 monday.com Ltd. Filed by: Glazer Eliran
-
Form N-PX/A Nuveen Core Equity Alpha For: Jun 30
-
Form N-PX/A Nushares ETF Trust For: Jun 30
-
Form N-PX/A Nuveen Global High Incom For: Jun 30
-
Form N-PX/A Nuveen NASDAQ 100 Dynami For: Jun 30
-
Form N-PX/A Nuveen Real Asset Income For: Jun 30
-
Form N-PX/A Nuveen Dow 30sm Dynamic For: Jun 30
-
Form D/A Stillpoint Investments
-
Form N-PX/A Nuveen Short Duration For: Jun 30
-
Form 4 Lazydays Holdings, Inc. For: May 15 Filed by: Shackelton Christopher S
-
Form N-PX/A Nuveen Investment Trust For: Jun 30
-
Form N-PX/A Nuveen S&P 500 Dynamic For: Jun 30
-
Form N-PX/A Nuveen Floating Rate For: Jun 30
-
Form N-PX/A NUVEEN FLOATING RATE For: Jun 30
-
Form 6-K RYANAIR HOLDINGS PLC For: May 17
-
Form N-PX/A NUVEEN MUNICIPAL HIGH For: Jun 30
-
Form N-PX/A Nuveen Credit Strategies For: Jun 30
-
Form N-PX/A NUVEEN SENIOR INCOME For: Jun 30
-
Form N-PX/A NUVEEN INVESTMENT TRUST For: Jun 30
-
Form D/A Stillpoint Onshore Inves
-
Form 6-K NOMURA HOLDINGS INC For: May 17
-
Form N-PX/A NUVEEN INVESTMENT TRUST For: Jun 30
-
Form N-PX/A NUVEEN INVESTMENT TRUST For: Jun 30
-
Form N-PX/A NUVEEN MULTISTATE TRUST For: Jun 30
-
Form N-PX/A NUVEEN INVESTMENT FUNDS For: Jun 30
-
Form D/A AB-LSV Partners I (Cayma
-
Form 6-K KOREA ELECTRIC POWER For: May 17
-
Form 6-K UNILEVER PLC For: May 17
-
Form 6-K iQIYI, Inc. For: May 17
-
Form DEFA14A Life360, Inc.
-
Form 10-Q SAFE & GREEN HOLDINGS For: Mar 31
-
Form 18-K/A URUGUAY REPUBLIC OF For: Dec 31
-
Form 10-K DXC Technology Co For: Mar 31
-
Form 8-K Erasca, Inc. For: May 16
-
Form N-CSR Oxford Lane Capital Corp For: Mar 31
-
Form 424B3 Feutune Light Acquisitio
-
Form C 2040 Energy, Inc
-
Form 424B2 CITIGROUP INC
-
Form 6-K SEQUANS COMMUNICATIONS For: May 17
-
Form DEFA14A BlackRock Science & Tech
-
Form D/A AB-LSV Partners I (Delaw
-
Form DEFA14A BlackRock ESG Capital
-
Form EFFECT Erayak Power Solution
-
Form EFFECT Captivision Inc.
-
Form SD ArcelorMittal
-
Form D/A BFAM Asian Opportunities
-
Form DEFA14A GENCO SHIPPING & TRADING
-
Form DEFA14A BlackRock Health Science
